Translating Clinical Evidence-Based Medicine into the Real World: Single-Center Experience with Cabazitaxel in Metastatic Prostate Cancer Patients.
Fiche publication
Date publication
janvier 2016
Journal
Chemotherapy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MERROUCHE Yacine
Tous les auteurs :
Moriceau G, Guillot A, Pacaut C, Méry B, Falk AT, Trone JC, Collard O, De Laroche G, Fournel P, Merrouche Y, Magné N
Lien Pubmed
Résumé
We studied the efficacy and safety of cabazitaxel in unselected real-life patients.
Mots clés
Antineoplastic Combined Chemotherapy Protocols, administration & dosage, Disease-Free Survival, Evidence-Based Medicine, Humans, Kaplan-Meier Estimate, Male, Neoplasm Metastasis, Prednisolone, administration & dosage, Prostatic Neoplasms, drug therapy, Retrospective Studies, Survival Rate, Taxoids, administration & dosage, Treatment Outcome
Référence
Chemotherapy. 2016 ;61(3):127-33